Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: January 2017

Bloomberg Index: New Jersey 4th Most Innovative State; Massachusetts Is No. 1 Followed by California

New Jersey pin horizontalNew York, NY, January 24, 2017 — According to the latest Bloomberg Index published in December 2016, New Jersey is the fourth most innovative state in the country.

Massachusetts, fueled by its higher-education institutions and an unemployment rate that is almost two points below the national average, was once again recognized as the top state for innovation with a total score of 94.82.

California and Washington followed Massachusetts in the rankings. Continue reading

FDA Establishes the Oncology Center of Excellence; Dr. Richard Pazdur to Serve as Director

FDA blueWashington, DC, January 23, 2017 — Outgoing Food and Drug Administration (FDA) Commissioner Dr. Robert Califf on January 19 announced that the agency was founding the Oncology Center of Excellence (OCE) and that Dr. Richard Pazdur would serve its inaugural director.

Califf said this will make oncology the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers. Continue reading

NJ Colleges’ Building Projects to Benefit from $34 Million Allocation from 2012 ‘Building Our Future Bond Act’

NJ SpotlightTrenton, NJ, January 23, 2017 — John Reitmeyer reports on NJ Spotlight that it has been more than four years since voters authorized a major bond issue to help pay for new buildings and renovations at New Jersey colleges and universities.

Now, lawmakers are taking steps to allocate $34 million, which represents the remaining dollars that have yet to be spent from that bond issue.

Committees in both the Assembly and Senate voted last week to approve a list of projects that will use up what remains of the $750 million “Building Our Future Bond Act” from 2012. Continue reading

NJIT and Talem Technologies Receive $600,000 Grant to Explore Exoskeleton in Duchenne Muscular Dystrophy

NJIT LogoNewark, NJ, January 22, 2017Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), on January 18 announced a $600,000 grant to be awarded to the New Jersey Institute of Technology (NJIT) and Talem Technologies (Talem) as part of the organization’s ongoing exploration of robotic technology to assist people living with Duchenne.

PPMD is funding a two-year study to incorporate NJIT’s technology – an embedded computer, software, a force sensor and a motor – as an add-on to an existing passive, spring-loaded device developed by Talem Technologies founder Blake Mathie as a zero-gravity support for people with Duchenne. Continue reading

Event: BioNJ’s Gateway Gala to Salute Patients, Innovator Companies and Leadership on February 2

bionj-2017-galaTrenton, NJ, January 21, 2017BioNJ will present Innovator Awards honoring industry leaders, policy champions and Patient advocates who have reached significant milestones, as well as companies with a footprint in New Jersey that have received a drug approval in 2016 during its 24th Annual Gateway Gala and Innovation Celebration taking place February 2 at the Hilton East Brunswick.

The Gateway Gala will feature the presentation of the tenth Dr. Sol J. Barer Award for Vision, Innovation and Leadership to Fred Hassan, Partner and Managing Director, Warburg Pincus and Former Chairman of the Board & CEO, Schering-Plough.   Continue reading

Governor Christie Launches ‘Help Is Within Reach’ Campaign; Unveils ReachNJ.gov and Helpline for Treatment, Services

Helpline christiesTrenton, NJ, January 20, 2017 — Further strengthening his commitment to helping those with substance abuse disease, as stated in his 2017 State of the State Address, Governor Chris Christie today launched a campaign to promote access to treatment and services for those impacted by addiction.

The new website, ReachNJ.gov, and helpline, 1-844-REACH-NJ, are designed to help those in need identify, prevent, treat and recover from substance abuse.

In this ad and throughout the campaign, Governor Christie will continue to emphasize that New Jersey is making it easier for residents to find resources available to them by going to the website or calling the help line. Continue reading

PhRMA: First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA Supply Chain Report 20170118Washington, DC, January 20, 2017 — Robust competition in the private marketplace is resulting in increasingly higher rebates and discounts on medicine prices, according to a new study by the Berkeley Research Group (BRG).

The Pharmaceutical Research and Manufacturers of America (PhRMA) commissioned the study.

The study is among the first to examine the share of prescription medicine spending retained by biopharmaceutical companies, generic manufacturers, pharmacy benefit managers (PBMs), health plans and other stakeholders in the supply chain. Continue reading

NIH Director Francis Collins to Stay on Under President Trump — At Least Now

Dr. Francis Collins

Dr. Francis Collins

Bethesda, MD, January 20, 2017 — Dylan Scott reports on STAT that Dr. Francis Collins is being held over as the director of the National Institutes of Health by the Trump administration, his office announced Thursday afternoon.

Dr. Collins had been prepared to step down from the post on Friday, after Trump’s inauguration, and return to his lab at the NIH Bethesda campus. However, with Thursday’s news, he will remain as director for the time being.

It is not yet known whether Trump will permanently reappoint Collins to be his NIH director for his full term. Collin’s office directed all further questions to the Trump transition. Continue reading

Alzheimer’s New Jersey Makes Its Way After Split from National Group

Alzheimer's New Jersey logoDenville, NJ, January 20, 2017 — Anajalee Khamlani reports on NJBIZ that, after completely rebranding and disassociating from the national Alzheimer’s Association, the 1-year-old Alzheimer’s New Jersey is standing on fairly stable ground.

There were some hiccups, such as donors being confused by the Greater New Jersey Alzheimer’s Association chapter and Alzheimer’s New Jersey’s new brand, as well as similar schedules for events and walks, but overall, things went smoothly, said CEO and President Kenneth Zaentz.

“We are definitely on track for what we want to accomplish,” he said. Continue reading

Rowan University/Rutgers-Camden Board of Governors Publish Report on Economic Impact on Camden and the State

Rutgers-Camden and Rowan UCamden, NJ, January 20, 2017 — The Rowan University/Rutgers-Camden Board of Governors (RURCBOG) has published an economic and fiscal impact report.

The 16-page report is attached to this email.  It also may be accessed online by clicking here.

The RURCBOG was created by the New Jersey Medical and Health Sciences Education Restructuring Act, which took effect on August 22, 2012.

The Board’s mission reflects an extension of Camden’s significant “eds and meds” presence and is expected to leverage the educational and research assets to support growth in the region’s health care capacity.